This is a human antibody that with high affinity for CD70, which is derived from hybridomas, and binds to renal cancer cell lines 786-0 and A-498 in a concentration-dependent manner. The KD of this antibody is approximately 1.6 nM for CD70-transfected CHO cells.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-336LC | Anti-Human CD70 Recombinant Antibody (Mb VLVH) | ELISA, FC, WB | Human antibody |
TAB-337LC | Anti-Human CD70 Recombinant Antibody (Mb VHVL) | ELISA, FC, WB | Human antibody |
TAB-338LC | Anti-Human CD70 Recombinant Antibody (VL-5-VH) | FC, WB | Human antibody |
TAB-339LC | Anti-Human CD70 Recombinant Antibody (VH-5-VL) | FC, WB | Human antibody |
TAB-340LC | Anti-Human CD70 Recombinant Antibody (VL-8-VH) | FC, WB | Human antibody |
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.